Corrigendum to “Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)” [Stem Cell Res. (43) 2020 101665] (Stem Cell Research (2020) 43, (S1873506119302958), (10.1016/j.scr.2019.101665))

Yicheng Ding; Eva Carvalho; Cormac Murphy; Veronica McInerney; Janusz Krawczyk; Timothy O'Brien; Linda Howard; Li Cai; Sanbing Shen

doi:10.1016/j.scr.2022.102850

Corrigendum to “Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)” [Stem Cell Res. (43) 2020 101665] (Stem Cell Research (2020) 43, (S1873506119302958), (10.1016/j.scr.2019.101665))

Yicheng Ding, Eva Carvalho, Cormac Murphy, Veronica McInerney, Janusz Krawczyk, Timothy O'Brien, Linda Howard, Li Cai, Sanbing Shen

Medicine

Research output: Contribution to a Journal (Peer & Non Peer) › Comment/debate

Abstract

We would like to thank three volunteers for participating in this study. This work was supported by Science Foundation Ireland – Investigator award (13/IA/1787) and FutureNeuro Centre grant (16/RC/3948) to SS, China Scholarship Council to YD, and the Basic Research Free Exploration Project of Shenzhen Science and Technology Innovation Commission JCYJ20180305124320418 and the Shenzhen University grant 2018QD026” to LC. The authors also acknowledge the facility and support of the HRB-Clinical Research Facility Galway – a unit of NUI Galway and Saolta University Health Care Group, Screening and Genomics Core Facility (http://ncbes.eurhost.net/screening-core-facility.aspx) and the Centre for Microscopy & Imaging (www.imaging.nuigalway.ie) funded by NUI Galway and the Irish Government's Programme for Research in Third Level Institutions, Cycles 4 and 5, National Development Plan 2007–2013. The authors would like to apologize for any inconvenience caused.

Original language	English
Article number	102850
Journal	Stem Cell Research
Volume	63
DOIs	https://doi.org/10.1016/j.scr.2022.102850
Publication status	Published - Aug 2022

Access to Document

10.1016/j.scr.2022.102850

Fingerprint

Dive into the research topics of 'Corrigendum to “Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)” [Stem Cell Res. (43) 2020 101665] (Stem Cell Research (2020) 43, (S1873506119302958), (10.1016/j.scr.2019.101665))'. Together they form a unique fingerprint.

Cite this

Ding, Y., Carvalho, E., Murphy, C., McInerney, V., Krawczyk, J., O'Brien, T., Howard, L., Cai, L., & Shen, S. (2022). Corrigendum to “Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)” [Stem Cell Res. (43) 2020 101665] (Stem Cell Research (2020) 43, (S1873506119302958), (10.1016/j.scr.2019.101665)). Stem Cell Research, 63, Article 102850. https://doi.org/10.1016/j.scr.2022.102850

Ding, Yicheng ; Carvalho, Eva ; Murphy, Cormac et al. / Corrigendum to “Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)” [Stem Cell Res. (43) 2020 101665] (Stem Cell Research (2020) 43, (S1873506119302958), (10.1016/j.scr.2019.101665)). In: Stem Cell Research. 2022 ; Vol. 63.

@article{ec55017878c142bc8e5bc3ba46c7b851,

title = "Corrigendum to “Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)” [Stem Cell Res. (43) 2020 101665] (Stem Cell Research (2020) 43, (S1873506119302958), (10.1016/j.scr.2019.101665))",

abstract = "We would like to thank three volunteers for participating in this study. This work was supported by Science Foundation Ireland – Investigator award (13/IA/1787) and FutureNeuro Centre grant (16/RC/3948) to SS, China Scholarship Council to YD, and the Basic Research Free Exploration Project of Shenzhen Science and Technology Innovation Commission JCYJ20180305124320418 and the Shenzhen University grant 2018QD026” to LC. The authors also acknowledge the facility and support of the HRB-Clinical Research Facility Galway – a unit of NUI Galway and Saolta University Health Care Group, Screening and Genomics Core Facility (http://ncbes.eurhost.net/screening-core-facility.aspx) and the Centre for Microscopy & Imaging (www.imaging.nuigalway.ie) funded by NUI Galway and the Irish Government's Programme for Research in Third Level Institutions, Cycles 4 and 5, National Development Plan 2007–2013. The authors would like to apologize for any inconvenience caused.",

author = "Yicheng Ding and Eva Carvalho and Cormac Murphy and Veronica McInerney and Janusz Krawczyk and Timothy O'Brien and Linda Howard and Li Cai and Sanbing Shen",

note = "Publisher Copyright: {\textcopyright} 2022",

year = "2022",

month = aug,

doi = "10.1016/j.scr.2022.102850",

language = "English",

volume = "63",

journal = "Stem Cell Research",

issn = "1873-5061",

}

Ding, Y, Carvalho, E, Murphy, C, McInerney, V, Krawczyk, J, O'Brien, T , Howard, L, Cai, L & Shen, S 2022, 'Corrigendum to “Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)” [Stem Cell Res. (43) 2020 101665] (Stem Cell Research (2020) 43, (S1873506119302958), (10.1016/j.scr.2019.101665))', Stem Cell Research, vol. 63, 102850. https://doi.org/10.1016/j.scr.2022.102850

Corrigendum to “Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)” [Stem Cell Res. (43) 2020 101665] (Stem Cell Research (2020) 43, (S1873506119302958), (10.1016/j.scr.2019.101665)). / Ding, Yicheng; Carvalho, Eva; Murphy, Cormac et al.
In: Stem Cell Research, Vol. 63, 102850, 08.2022.

Research output: Contribution to a Journal (Peer & Non Peer) › Comment/debate

TY - JOUR

T1 - Corrigendum to “Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)” [Stem Cell Res. (43) 2020 101665] (Stem Cell Research (2020) 43, (S1873506119302958), (10.1016/j.scr.2019.101665))

AU - Ding, Yicheng

AU - Carvalho, Eva

AU - Murphy, Cormac

AU - McInerney, Veronica

AU - Krawczyk, Janusz

AU - O'Brien, Timothy

AU - Howard, Linda

AU - Cai, Li

AU - Shen, Sanbing

PY - 2022/8

Y1 - 2022/8

N2 - We would like to thank three volunteers for participating in this study. This work was supported by Science Foundation Ireland – Investigator award (13/IA/1787) and FutureNeuro Centre grant (16/RC/3948) to SS, China Scholarship Council to YD, and the Basic Research Free Exploration Project of Shenzhen Science and Technology Innovation Commission JCYJ20180305124320418 and the Shenzhen University grant 2018QD026” to LC. The authors also acknowledge the facility and support of the HRB-Clinical Research Facility Galway – a unit of NUI Galway and Saolta University Health Care Group, Screening and Genomics Core Facility (http://ncbes.eurhost.net/screening-core-facility.aspx) and the Centre for Microscopy & Imaging (www.imaging.nuigalway.ie) funded by NUI Galway and the Irish Government's Programme for Research in Third Level Institutions, Cycles 4 and 5, National Development Plan 2007–2013. The authors would like to apologize for any inconvenience caused.

AB - We would like to thank three volunteers for participating in this study. This work was supported by Science Foundation Ireland – Investigator award (13/IA/1787) and FutureNeuro Centre grant (16/RC/3948) to SS, China Scholarship Council to YD, and the Basic Research Free Exploration Project of Shenzhen Science and Technology Innovation Commission JCYJ20180305124320418 and the Shenzhen University grant 2018QD026” to LC. The authors also acknowledge the facility and support of the HRB-Clinical Research Facility Galway – a unit of NUI Galway and Saolta University Health Care Group, Screening and Genomics Core Facility (http://ncbes.eurhost.net/screening-core-facility.aspx) and the Centre for Microscopy & Imaging (www.imaging.nuigalway.ie) funded by NUI Galway and the Irish Government's Programme for Research in Third Level Institutions, Cycles 4 and 5, National Development Plan 2007–2013. The authors would like to apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85132933464&partnerID=8YFLogxK

U2 - 10.1016/j.scr.2022.102850

DO - 10.1016/j.scr.2022.102850

M3 - Comment/debate

C2 - 35772298

AN - SCOPUS:85132933464

SN - 1873-5061

VL - 63

JO - Stem Cell Research

JF - Stem Cell Research

M1 - 102850

ER -

Ding Y, Carvalho E, Murphy C, McInerney V, Krawczyk J, O'Brien T et al. Corrigendum to “Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)” [Stem Cell Res. (43) 2020 101665] (Stem Cell Research (2020) 43, (S1873506119302958), (10.1016/j.scr.2019.101665)). Stem Cell Research. 2022 Aug;63:102850. doi: 10.1016/j.scr.2022.102850

Corrigendum to “Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A)” [Stem Cell Res. (43) 2020 101665] (Stem Cell Research (2020) 43, (S1873506119302958), (10.1016/j.scr.2019.101665))

Abstract

Access to Document

Other files and links

Fingerprint

Cite this